JSPR Long Call Strategy
JSPR (Jasper Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
JSPR (Jasper Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $15.0M, a beta of 3.08 versus the broader market, a 52-week range of 0.623-7.19, average daily share volume of 415K, a public-listing history dating back to 2020, approximately 64 full-time employees. These structural characteristics shape how JSPR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 3.08 indicates JSPR has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on JSPR?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current JSPR snapshot
As of May 15, 2026, spot at $0.83, ATM IV 27.40%, IV rank 2.73%, expected move 7.86%. The long call on JSPR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on JSPR specifically: JSPR IV at 27.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a JSPR long call, with a market-implied 1-standard-deviation move of approximately 7.86% (roughly $0.07 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated JSPR expiries trade a higher absolute premium for lower per-day decay. Position sizing on JSPR should anchor to the underlying notional of $0.83 per share and to the trader's directional view on JSPR stock.
JSPR long call setup
The JSPR long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With JSPR near $0.83, the first option leg uses a $0.83 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed JSPR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 JSPR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.83 | N/A |
JSPR long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
JSPR long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on JSPR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on JSPR
Long calls on JSPR express a bullish thesis with defined risk; traders use them ahead of JSPR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
JSPR thesis for this long call
The market-implied 1-standard-deviation range for JSPR extends from approximately $0.76 on the downside to $0.90 on the upside. A JSPR long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current JSPR IV rank near 2.73% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on JSPR at 27.40%. As a Healthcare name, JSPR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to JSPR-specific events.
JSPR long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. JSPR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move JSPR alongside the broader basket even when JSPR-specific fundamentals are unchanged. Long-premium structures like a long call on JSPR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current JSPR chain quotes before placing a trade.
Frequently asked questions
- What is a long call on JSPR?
- A long call on JSPR is the long call strategy applied to JSPR (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With JSPR stock trading near $0.83, the strikes shown on this page are snapped to the nearest listed JSPR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are JSPR long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the JSPR long call priced from the end-of-day chain at a 30-day expiry (ATM IV 27.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a JSPR long call?
- The breakeven for the JSPR long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current JSPR market-implied 1-standard-deviation expected move is approximately 7.86%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on JSPR?
- Long calls on JSPR express a bullish thesis with defined risk; traders use them ahead of JSPR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current JSPR implied volatility affect this long call?
- JSPR ATM IV is at 27.40% with IV rank near 2.73%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.